CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 55 target
Drug / intervention
Methylprednisolone 125mg +1 moredrug
Likely dose
Methylprednisolone 125mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01106547
NCT01106547Phase 4Completed
CompareCT.gov

The Effect of a Preoperative Single-dose Methylprednisolone on the Postoperative Rehabilitation After Abdominal Hysterectomy: A Prospective, Double Blinded, Placebo Controlled Study

Holbaek Sygehus·interventional·Posted Apr 20, 2010·Updated Oct 13, 2011

In Brief

A Phase 4 clinical trial evaluating Methylprednisolone 125mg and Sodium Chloride 2 ml for Hysterectomy and 2 related conditions. Completed, enrolled 55 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the effect of 125 mg methylprednisolone, given intravenously 60-90 minutes before abdominal surgery,on the postoperative rehabilitation after abdominal hysterectomy.Sodium Chloride is the placebo. The following parameters are registered: 1. Pain 3, 6 and 24 hours postoperatively and 2-7 days after surgery. 2. The postoperative use of additional analgesics. 3. Inflammatory parameters before and after surgery. 4. Time until mobilization. 5. Time until discharge.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHysterectomy, Methylprednisolone, Postoperative Pain
CountriesDenmark
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 20, 2010
Enrollment StartAug 1, 2009
Primary CompletionSep 1, 2011
Study CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 16.2 years ago

Interventions

Methylprednisolone 125mgdrug

Single dose 60-90 minutes preoperatively

Sodium Chloride 2 mldrug

Single dose 60-90 min preoperatively